You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 16, Issue 4

February-2 2024 - 163 articles

Cover Story: Epiregulin (EREG), a member of the EGF family, binds to the EGFR and ErbB4, and it stimulates EGFR-related downstream pathways. Increasing evidence indicates that EREG plays a pivotal role in the development of many human cancers, including non-small cell lung cancer. EREG overexpression is induced by activating mutations in the EGFR, KRAS, and BRAF and contributes to the aggressive phenotypes of non-small cell lung cancer with such oncogenic drivers. Recent studies have elucidated the roles of EREG in a tumor microenvironment, including the epithelial–mesenchymal transition, angiogenesis, immune evasion, and resistance to anticancer therapy. Here, we summarized the current understanding of EREG as an oncogene and discussed its oncogenic role in lung tumorigenesis and therapeutic resistance. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (163)

  • Article
  • Open Access
4 Citations
2,402 Views
14 Pages

Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade

  • Soong June Bae,
  • Jee Hung Kim,
  • Min Ji Lee,
  • Seung Ho Baek,
  • Yoonwon Kook,
  • Sung Gwe Ahn,
  • Yoon Jin Cha and
  • Joon Jeong

19 February 2024

In patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, achievement of pathologic complete response (pCR) is a known prognostic indicator after neoadjuvant systemic therapy (NAST). We investigated the clinicopathologi...

  • Article
  • Open Access
2 Citations
1,786 Views
11 Pages

Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors

  • Takuto Shimizu,
  • Makito Miyake,
  • Nobutaka Nishimura,
  • Takanori Yoshida,
  • Yoshitaka Itami,
  • Akira Tachibana,
  • Chihiro Omori,
  • Yuki Oda,
  • Mikiko Kohashi and
  • Mitsuru Tomizawa
  • + 8 authors

19 February 2024

Complete metastasectomy (CM) in metastatic renal cell carcinoma (mRCC) has demonstrated efficacy in the cytokine era, but its effectiveness in the era of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) remains unclear. A mul...

  • Article
  • Open Access
6 Citations
3,041 Views
24 Pages

Identifying PLAUR as a Pivotal Gene of Tumor Microenvironment and Regulating Mesenchymal Phenotype of Glioblastoma

  • Zaixiang Fu,
  • Zihang Chen,
  • Jingya Ye,
  • Jianxiong Ji,
  • Weifang Ni,
  • Weibo Lin,
  • Haopu Lin,
  • Liquan Lu,
  • Ganggui Zhu and
  • Qin Xie
  • + 3 authors

19 February 2024

The mesenchymal (MES) phenotype of glioblastoma (GBM) is the most aggressive and therapy-resistant subtype of GBM. The MES phenotype transition during tumor progression results from both tumor-intrinsic genetic alterations and tumor-extrinsic microen...

  • Systematic Review
  • Open Access
13 Citations
3,592 Views
16 Pages

FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature

  • Priscilla Guglielmo,
  • Pierpaolo Alongi,
  • Lucia Baratto,
  • Miriam Conte,
  • Elisabetta Maria Abenavoli,
  • Ambra Buschiazzo,
  • Greta Celesti,
  • Francesco Dondi,
  • Rossella Filice and
  • Joana Gorica
  • + 11 authors

19 February 2024

(1) Background: Thyroid cancer (TC) is often treated with surgery followed by iodine-131. Up to 50% of the instances of TC lose their avidity to 131I, becoming more aggressive. In this scenario, [18F]FDG PET/CT imaging is used for evaluating the wide...

  • Article
  • Open Access
5 Citations
5,544 Views
18 Pages

Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma

  • Sang Youn Hwang,
  • Hyun Young Woo,
  • Jeong Heo,
  • Hyung Jun Kim,
  • Young Joo Park,
  • Ki Youn Yi,
  • Yu Rim Lee,
  • Soo Young Park,
  • Woo Jin Chung and
  • Byoung Kuk Jang
  • + 1 author

19 February 2024

Real-world data regarding treatment with atezolizumab plus bevacizumab in high-risk patients with advanced HCC are lacking. In this multicenter retrospective cohort study, a total of 215 patients with advanced HCC received atezolizumab plus bevacizum...

  • Article
  • Open Access
3 Citations
2,994 Views
11 Pages

Atypical Ductal Hyperplasia and Lobular In Situ Neoplasm: High-Risk Lesions Challenging Breast Cancer Prevention

  • Luca Nicosia,
  • Luciano Mariano,
  • Giuseppe Pellegrino,
  • Federica Ferrari,
  • Filippo Pesapane,
  • Anna Carla Bozzini,
  • Samuele Frassoni,
  • Vincenzo Bagnardi,
  • Davide Pupo and
  • Giovanni Mazzarol
  • + 5 authors

19 February 2024

This retrospective study investigates the histopathological outcomes, upgrade rates, and disease-free survival (DFS) of high-risk breast lesions, including atypical ductal hyperplasia (ADH or DIN1b) and lobular in situ neoplasms (LIN), following Vacu...

  • Review
  • Open Access
7 Citations
2,965 Views
25 Pages

Role of Cyclins and Cytoskeletal Proteins in Endometriosis: Insights into Pathophysiology

  • Marcin Szymański,
  • Klaudia Bonowicz,
  • Paulina Antosik,
  • Dominika Jerka,
  • Mariola Głowacka,
  • Małgorzata Soroka,
  • Kerstin Steinbrink,
  • Konrad Kleszczyński and
  • Maciej Gagat

19 February 2024

Endometriosis is a gynecological condition where endometrium-like tissue grows outside the uterus, posing challenges in understanding and treatment. This article delves into the deep cellular and molecular processes underlying endometriosis, with a f...

  • Article
  • Open Access
3 Citations
2,626 Views
11 Pages

Safety and Diagnostic Efficacy of Image-Guided Biopsy of Small Renal Masses

  • Muhamad Serhal,
  • Sean Rangwani,
  • Stephen M. Seedial,
  • Bartley Thornburg,
  • Ahsun Riaz,
  • Albert A. Nemcek,
  • Kent T. Sato,
  • Kent T. Perry,
  • Bonnie Choy and
  • Robert J. Lewandowski
  • + 1 author

19 February 2024

Introduction: Image-guided renal mass biopsy is gaining increased diagnostic acceptance, but there are limited data concerning the safety and diagnostic yield of biopsy for small renal masses (≤4 cm). This study evaluated the safety, diagnostic yi...

  • Article
  • Open Access
1 Citations
3,190 Views
22 Pages

The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells

  • Sophia S. Borisevich,
  • Tatiana E. Aksinina,
  • Margarita G. Ilyina,
  • Victoria O. Shender,
  • Ksenia S. Anufrieva,
  • Georgij P. Arapidi,
  • Nadezhda V. Antipova,
  • Fabrice Anizon,
  • Yannick J. Esvan and
  • Francis Giraud
  • + 5 authors

19 February 2024

Serine-threonine protein kinases of the DYRK and CLK families regulate a variety of vital cellular functions. In particular, these enzymes phosphorylate proteins involved in pre-mRNA splicing. Targeting splicing with pharmacological DYRK/CLK inhibito...

  • Article
  • Open Access
6 Citations
1,849 Views
12 Pages

19 February 2024

The purpose of this study was to investigate the association between preoperative inflammation and postoperative complications in gastric cancer patients having elective gastrectomy. Participants in this study were those who underwent radical gastrec...

of 17

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694Creative Common CC BY license